Omnicell falls as KeyBanc downgrades rating to 'sector weight'

Omnicell

11/10/2023 18:11

** Shares of drug management system maker Omnicell  OMCL.O 
fall ~3.2% to $44.35 
    ** KeyBanc downrades stock rating to "sector weight" from
"overweight"
        ** Brokerage says OMCL's profitability metrics have been
lowered due to a reduced demand environment for hospital systems
    ** Suggests that some customers of co's automated drug
dispenser XT Series cabinets are deciding to convert to Becton
Dickinson's  BDX.N  Pyxis cabinets next year
    ** Four of eight brokerages rate the stock "buy" or higher,
three "hold" and one "sell" or lower; their median PT is $75
    ** Including session moves, stock down ~12.2% YTD
    

 (Reporting by Christy Santhosh)
 ((Christy.Santhosh@thomsonreuters.com))